Is Colgate-Palmolive Still Recession-Proof? | CL Q1 2026 Analysis

Welcome back to Iron Financial. We don’t chase hype; we build portfolios on facts and cold, hard data. Today, we’re putting Colgate-Palmolive (CL) under the hydraulic press. With the Q1 2026 earnings report on the horizon and the 2025 10-K filed, it’s time to see if this consumer staple giant is actually doing the heavy lifting for your portfolio or if the margins are starting to bleed. We dive deep into: The Q1 2026 Outlook: What the newest data tells us about revenue and debt. Dividend Longevity: 63 years of increases is impressive, but is it sustainable in 2026? Strategic Priorities: Can their AI and data analytics shift actually move the needle, or is it just corporate fluff? Don’t let market weakness erode your gains. We analyze the margins, the segments (from Oral Health to Pet Nutrition), and the management's prepared remarks to give you the ultimate verdict.

Added 2 May 2026